why choose us

First received: May 12, 2025

Clinical Trial: A Study to Assess the Safety and Tolerability, and Pharmacokinetics of UCB0022 in Healthy Caucasian, Japanese, and Chinese Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy Study Participants

Study Type: INTERVENTIONAL


Official Title: A Single-center, Placebo-controlled, Participant-blind, Investigator-blind, Randomized, Multiple Ascending Dose in Titration Study to Assess The Safety and Tolerability, and Pharmacokinetics of UCB002

Brief Summary: The primary purpose of this study is to assess the safety and tolerability of oral glovadalen (UCB0022) in healthy Caucasian, Japanese, and Chinese participants.

Read more